MAIA Biotechnology (MAIA) Payables (2021 - 2026)
MAIA Biotechnology (MAIA) recorded Payables of $2.84 million in Q2 2026, up 64.7% from $1.72 million a year earlier but down 4.8% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, MAIA Biotechnology reported Payables of $2.04 million, up 34.8% from FY2024.
- Annual Payables has a four-year compound annual growth rate of 20.7% (FY2021 to FY2025).
- Across earlier years, Payables came in at $1.51 million in FY2024 (-7.7%), $1.64 million in FY2023 (+40.6%), $1.17 million in FY2022 (+21.4%) and $960,401 in FY2021.
- Quarterly Payables has ranged from $960,401 in Q4 2021 to $3.18 million in Q3 2025 over the past five years.
- On a year-over-year basis, Payables has increased for five consecutive quarters, with growth averaging 44.8% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 175.7% in Q3 2025, against a decline of 18.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.98 million (Q1 2026), $2.04 million (Q4 2025) and $3.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,174.91 Bn | 1,143.49 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.40 Bn | 562.93 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.86 Bn | 476.97 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 379.74 Bn | 334.12 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 303.49 Bn | 267.48 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 269.36 Bn | 243.04 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 243.43 Bn | 198.83 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.94 Bn | 119.58 Bn | 10.94 Bn | 7.03 Bn |
| 10 | MAIA Biotechnology | 68.70 Mn | -12.86 Mn | - | 2.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.84 Mn |
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Dec 31, 2021 | 960,401.00 |
API Access
MAIA Biotechnology Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();